Zurich Insurance Group Ltd : There is still some upside potential
Entry price | Target | Stop-loss | Potential |
---|
CHF 350.7 |
CHF 375 |
CHF 331.1 |
+6.93% |
---|
The underlying tendency is to the upside for shares in Zurich Insurance Group and the timing is opportune to get back into the stock. A comeback of the upward dynamic can be anticipated.
Summary● The company has solid fundamentals for a short-term investment strategy.
Strengths● This company will be of major interest to investors in search of a high dividend stock.
● The tendency within the weekly time frame is positive above the technical support level at 316.5 CHF
Weaknesses● Stock prices approach a strong long-term resistance in weekly data at CHF 349.
● The stock is close to a major daily resistance at CHF 351.1, which should be gotten rid of so as to gain new appreciation potential.
● According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
● For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.